Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy

ClinicalTrials.gov ID: NCT01538680

Public ClinicalTrials.gov record NCT01538680. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 2:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Phase IIIb Study of Regorafenib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy

Study identification

NCT ID
NCT01538680
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Bayer
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Regorafenib (BAY73-4506) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
May 28, 2019

United States locations

U.S. sites
62
U.S. states
31
U.S. cities
56
Facility City State ZIP Site status
Not listed Duarte California 91010
Not listed La Jolla California 92037
Not listed La Jolla California 92093-0987
Not listed Long Beach California 90813
Not listed Los Angeles California 90033
Not listed Orange California 92868-3201
Not listed Santa Maria California 93454
Not listed Denver Colorado 80218
Not listed New Haven Connecticut 06520
Not listed Washington D.C. District of Columbia 20007
Not listed Aventura Florida 33180
Not listed Jacksonville Florida 32224
Not listed Miami Beach Florida 33140
Not listed Ocala Florida 34474
Not listed Orlando Florida 32804
Not listed Atlanta Georgia 30318
Not listed Columbus Georgia 31904
Not listed Savannah Georgia 31405
Not listed Park Ridge Illinois 60068
Not listed Cedar Rapids Iowa 52403
Not listed Sioux City Iowa 51101
Not listed Louisville Kentucky 40202
Not listed New Orleans Louisiana 70121
Not listed Shreveport Louisiana 71130
Not listed Brewer Maine 04412
Not listed Boston Massachusetts 02215-5450
Not listed Burlington Massachusetts 01805
Not listed Ann Arbor Michigan 48106
Not listed Detroit Michigan 48201
Not listed Detroit Michigan 48202
Not listed Rochester Minnesota 55905
Not listed Jackson Mississippi 39202
Not listed Jefferson City Missouri 65109
Not listed Omaha Nebraska 68106
Not listed Las Vegas Nevada 89169
Not listed Lebanon New Hampshire 03756
Not listed Lake Success New York 11042
Not listed New York New York 10003
Not listed New York New York 10016
Not listed New York New York 10021
Not listed Stony Brook New York 11794
Not listed The Bronx New York 10461
Not listed Charlotte North Carolina 28203
Not listed Winston-Salem North Carolina 27157
Not listed Fargo North Dakota 58122
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44195
Not listed Toledo Ohio 43617
Not listed Portland Oregon 97239
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19107
Not listed Philadelphia Pennsylvania 19111-2497
Not listed Providence Rhode Island 02908
Not listed Charleston South Carolina 29414
Not listed Sumter South Carolina 29150
Not listed Memphis Tennessee 38120
Not listed Nashville Tennessee 37232
Not listed Dallas Texas 75390-9110
Not listed Temple Texas 76508
Not listed Portsmouth Virginia 23704
Not listed Richmond Virginia 23298-0037
Not listed Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 145 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01538680, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2019 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01538680 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →